Streetbeat News

Price Targets

SNAP

JP Morgan analyst Doug Anmuth maintains an Underweight rating on Snap (NYSE:SNAP) and raises the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:37 pm

PCAR

JP Morgan analyst Tami Zakaria maintains an Overweight rating on PACCAR (NASDAQ:PCAR) and raises the price target from $105 to $107.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:36 pm

LOGI

JP Morgan analyst Paul Chung maintains an Overweight rating on Logitech International (NASDAQ:LOGI) and raises the price target from $81 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:35 pm

IVZ

JP Morgan analyst Kenneth Worthington maintains a Neutral rating on Invesco (NYSE:IVZ) and raises the price target from $15 to $15.5.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:29 pm

SNOW

A significant number of investors have taken a bearish stance on Snowflake (NYSE:SNOW), with 66% of detected trades showing bearish expectations. The targeted price range for Snowflake over the last 3 months is from $120.0 to $250.0. The current price of SNOW is down -5.2% at $143.26. Mizuho and B of A Securities have downgraded their actions on Snowflake, while Piper Sandler maintains their Overweight rating.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 6:16 pm

AMRN

Jefferies has downgraded Amarin's stock from Buy to Hold and reduced its price target from $3 to $1, causing the shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:10 pm

FTCH

Farfetch's stock has been downgraded from Buy to Sell by Societe Generale, with a new price target of $1.5. This has led to a decrease in Farfetch's share price.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:08 pm

SRRK

Jefferies has upgraded Scholar Rock's stock from Hold to Buy and set a price target of $20. This has resulted in Scholar Rock's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:03 pm

NBN

Piper Sandler analyst Alexander Twerdahl has maintained an Overweight rating on Northeast Bank (NASDAQ:NBN) and raised the price target from $52 to $54.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:55 pm

RARE

Piper Sandler analyst Christopher Raymond has maintained an Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) but lowered the price target from $135 to $130.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 5:53 pm